“food-and-drug-administration” Archives

in
Entry Author Date Location
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug 01/17/17 Boston
Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA 01/12/17 Boston
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial 01/10/17 San Francisco
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio 01/09/17 Boston
Biopharma Industry, Heal Thyself (Without Government Help) 01/06/17 San Diego
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial 12/29/16 Raleigh Durham
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis 12/20/16 San Diego
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease 12/14/16 Boston
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet 12/13/16 Boston
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
Senate Approves 21st Century Cures Act, Sending Bill to Obama 12/07/16 National
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal 12/02/16 Boston
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies 11/29/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes 10/20/16 Texas
Eli Lilly Wins FDA Nod for New Soft Tissue Sarcoma Drug 10/20/16 Indiana
Aquaculture Industry Casts Wider Net in Food and Consumer Markets 10/13/16 Raleigh Durham
Bio Execs Talk Patient Advocacy, Duchenne Approval at BioForward Panel 09/28/16 Wisconsin
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
Novan Files for IPO to Finance ‘Nitric Oxide on Demand’ Skin Drugs 08/25/16 Raleigh Durham
Imbed Biosciences Nabs $600K For Infection-Preventing Wound Dressing 08/18/16 Wisconsin
EyeKor Stares Down $600K to Develop Clinical Trial Software 08/09/16 Wisconsin
Arrowhead Pharmaceuticals CEO on Name Change, Clinical Trial Progress 07/21/16 Wisconsin
Zimmer Biomet Enters Robotic Surgery Space with Medtech Deal 07/19/16 Indiana
Page 1 of 4 next page »